Protagenic Therapeutics, Inc.\new Net Cash Provided by (Used in) Investing Activities, Continuing Operations
Protagenic Therapeutics, Inc.\new (PTIX) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of -$1.83 million for the 6-month period ending 2017-06-30, per its 10-Q filed 2017-08-08.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2017-08-08
- Protagenic Therapeutics, Inc.\new net cash provided by (used in) investing activities, continuing operations for the quarter ending 2015-06-30 was $0.00.
- Protagenic Therapeutics, Inc.\new net cash provided by (used in) investing activities, continuing operations for the quarter ending 2015-03-31 was -$1.00K.
- Protagenic Therapeutics, Inc.\new net cash provided by (used in) investing activities, continuing operations for the quarter ending 2014-12-31 was $0.00.
- Protagenic Therapeutics, Inc.\new net cash provided by (used in) investing activities, continuing operations for the quarter ending 2014-09-30 was $0.00.
- Protagenic Therapeutics, Inc.\new net cash provided by (used in) investing activities, continuing operations for fiscal 2015 was -$1.79K.
- Protagenic Therapeutics, Inc.\new net cash provided by (used in) investing activities, continuing operations for fiscal 2015 was -$1.00K.
- Protagenic Therapeutics, Inc.\new net cash provided by (used in) investing activities, continuing operations for fiscal 2014 was -$1.00K.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month |
|---|---|---|---|---|
| 2017-06-30 | -$1.83M 10-Q · filed 2017-08-08 | |||
| 2015-12-31 | -$1.79K 10-K/A · filed 2017-05-08 | |||
| 2015-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-09-25 | -$1.00K derived: sum of 2 quarters · filed 2015-09-25 | -$1.00K derived: sum of 3 quarters · filed 2015-09-25 | -$1.00K 10-K · filed 2015-09-25 |
| 2015-03-31 | -$1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-05-11 | -$1.00K derived: sum of 2 quarters · filed 2015-05-11 | -$1.00K 10-Q · filed 2015-05-11 | -$1.00K derived: sum of 4 quarters · filed 2015-09-25 |
| 2014-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-02-06 | $0.00 10-Q · filed 2015-02-06 | $0.00 derived: sum of 3 quarters · filed 2015-09-25 | $0.00 derived: sum of 4 quarters · filed 2015-09-25 |
| 2014-09-30 | $0.00 10-Q · filed 2014-11-13 | $0.00 derived: sum of 2 quarters · filed 2015-09-25 | $0.00 derived: sum of 3 quarters · filed 2015-09-25 | $0.00 derived: sum of 4 quarters · filed 2015-09-25 |
| 2014-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-09-25 | $0.00 derived: sum of 2 quarters · filed 2015-09-25 | $0.00 derived: sum of 3 quarters · filed 2015-09-25 | -$1.00K 10-K · filed 2015-09-25 |
| 2014-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-05-11 | $0.00 derived: sum of 2 quarters · filed 2015-05-11 | -$1.00K 10-Q · filed 2015-05-11 | |
| 2013-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-02-06 | -$1.00K 10-Q · filed 2015-02-06 | ||
| 2013-09-30 | -$1.00K 10-Q · filed 2014-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |